Prevent Kidney Disease
Learn more to reduce your risk of kidney disease and take the pledge to #preventkidneydisease.
The National Kidney Foundation Board of Directors appoints the KDOQI Chair and Vice Chairs, who provide overall direction and ongoing guidance to the initiative. They interact closely with the KDOQI work groups and work group chairs, preside over KDOQI meetings and serve as KDOQI spokespeople.
Michael Rocco, M.D.
Jeffrey Berns, M.D.
Vice Chair, Guidelines and Commentary
Holly Kramer, M.D.
Vice Chair, Research
Michael J. Choi, M.D.
Vice Chair, Education
Michael V. Rocco, M.D., M.S.C.E., is Professor of Medicine at Wake Forest University in Winston-Salem, North Carolina. He received his MD degree from Vanderbilt University in Nashville, Tennessee and also served his Internal Medicine residency at Vanderbilt. He completed a nephrology fellowship at the University of Pennsylvania in Philadelphia, Pennsylvania and received a master's degree in epidemiology at Wake Forest University. He has been on the faculty of the Wake Forest University School of Medicine since 1991 and currently holds the Vardaman M. Buckalew Jr. Chair in Nephrology. He has more than 100 manuscripts and book chapters in the areas of hemodialysis, peritoneal dialysis, nutrition, chronic renal failure and epidemiology. He has served as the clinical center Principal Investigator at Wake Forest for several NIH trials, including the HEMO Study, the Acute Renal Failure Trial Network (ATN), the Dialysis Access Consortium (DAC) and the Frequent Hemodialysis Network (FHN). In the HEMO Study he served as the Chair of the Nutrition committee and the Vice-Chair of the Outcomes Committee. In the FHN Trial, he is the Clinical Core Consortium PI for the Nocturnal Trial and the Chair of the Outcomes Committee. Dr. Rocco is currently the Chair of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI); he served as the Vice-Chair for KDOQI from 2003 - 2007 and was the vice-chair for the NKF KDOQI Hypertension Work Group.
Jeffrey S. Berns, M.D., Professor of Medicine and Pediatrics at the University of Pennsylvania School of Medicine, Director of the University of Pennsylvania Renal Fellowship Training Program, and Interim Chief of the Penn Renal-Electrolyte and Hypertension Division.
He has served as a member of the KDOQI Anemia Workgroup since its inception and has served on the editorial boards of Seminars in Dialysis, AJKD, CJASN, and is Deputy Editor of NephSAP. He has published in the areas of anemia in CKD, renal pharmacology, renal aspects of HIV infection, among others. Dr. Berns received his medical degree and completed his residency training in Internal Medicine at Case Western Reserve University School of Medicine and completed a Fellowship in Nephrology at Yale University.
Holly J. Kramer, M.D., is an associate professor and a kidney disease specialist at the Loyola University Medical Center who studies the epidemiology of kidney disease including both environmental and genetic factors for incidence and progression. After graduating from Indiana University School of Medicine, Indianapolis, Dr. Kramer trained in internal medicine at Emory University School of Medicine.
Dr. Kramer specialized in nephrology through a fellowship at the Harvard-affiliated Massachusetts General Hospital and Brigham and Women's Hospital, Boston. She also holds a master's degree in public health from the Harvard School of Public Health.
Dr. Choi is trained in Molecular Biophysics and Biochemistry after graduating from the Yale University, and received his Postdoctoral from the Penn Center of Molecular Studies of Kidney Disease, followed by his fellowship training at the University Of Pennsylvania School Of Medicine.
His clinical interests are primary glomerular diseases and nephrolithiasis. Dr. Choi is the co-editor of the Oxford Manual of Nephrology, Deputy Editor of Advances in Chronic Kidney Diseases, and Co-Chair of the NKF Spring 2010 Clinical Meeting.